Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome
- PMID: 18308097
- PMCID: PMC2390769
- DOI: 10.1016/j.urology.2007.09.025
Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome
Abstract
Objectives: To identify adrenocortical hormone abnormalities as indicators of endocrine dysfunction in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Methods: We simultaneously measured the serum concentrations of 12 steroids in patients with CP/CPPS and controls, using isotope dilution liquid chromatography, followed by atmospheric pressure photospray ionization and tandem mass spectrometry.
Results: We evaluated 27 patients with CP/CPPS and 29 age-matched asymptomatic healthy controls. In the mineralocorticoid pathway, progesterone was significantly greater, and the corticosterone and aldosterone concentrations were significantly lower, in the patients with CP/CPPS than in the controls. In the glucocorticoid pathway, 11-deoxycortisol was significantly lower and the cortisol concentrations were not different between the patients and controls. In the sex steroid pathway, the androstenedione and testosterone concentrations were significantly greater in those with CP/CPPS than in the controls. The estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate concentrations were not different between the patients and controls. The National Institutes of Health-Chronic Prostatitis Symptom Index total and pain domain scores correlated positively with the 17-hydroxyprogesterone and aldosterone (P <0.001) and negatively with the cortisol (P <0.001) concentrations.
Conclusions: Our results suggest reduced activity of CYP21A2 (P450c21), the enzyme that converts progesterone to corticosterone and 17-hydroxyprogesterone to 11-deoxycortisol. Furthermore, these results provide insights into the biologic basis of CP/CPPS. Follow-up studies should explore the possibility that patients with CP/CPPS meet the diagnostic criteria for nonclassic congenital adrenal hyperplasia and whether the hormonal findings improve or worsen in parallel with symptom severity.
Conflict of interest statement
Conflict of Interest Disclosures:
The following individuals have NO relevant financial interests in the manuscript: Jordan D. Dimitrakov, Hylton V. Joffe, Steven J. Soldin, Roger Bolus, CA Tony Buffington
Figures

Similar articles
-
Characterization of circulating CD4+CD25high regulatory T cells in men with chronic prostatitis/chronic pelvic pain syndrome.Urology. 2010 Apr;75(4):938-42. doi: 10.1016/j.urology.2009.07.1229. Epub 2009 Oct 2. Urology. 2010. PMID: 19800664
-
Evaluation of psychological stress, cortisol awakening response, and heart rate variability in patients with chronic prostatitis/chronic pelvic pain syndrome complicated by lower urinary tract symptoms and erectile dysfunction.Front Psychol. 2022 Nov 4;13:903250. doi: 10.3389/fpsyg.2022.903250. eCollection 2022. Front Psychol. 2022. PMID: 36405196 Free PMC article.
-
Experimental Chronic Prostatitis/Chronic Pelvic Pain Syndrome Increases Anxiety-Like Behavior: The Role of Brain Oxidative Stress, Serum Corticosterone, and Hippocampal Parvalbumin-Positive Interneurons.Oxid Med Cell Longev. 2021 Mar 2;2021:6687493. doi: 10.1155/2021/6687493. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33815658 Free PMC article.
-
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.Eur Urol. 2016 Feb;69(2):286-97. doi: 10.1016/j.eururo.2015.08.061. Epub 2015 Sep 26. Eur Urol. 2016. PMID: 26411805 Review.
-
Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.Drugs Aging. 2003;20(15):1111-25. doi: 10.2165/00002512-200320150-00004. Drugs Aging. 2003. PMID: 14651434 Review.
Cited by
-
Interstitial Cystitis - Elucidation of Psychophysiologic and Autonomic Characteristics (the ICEPAC Study): design and methods.J Pain Res. 2014 May 8;7:243-53. doi: 10.2147/JPR.S58853. eCollection 2014. J Pain Res. 2014. PMID: 24855387 Free PMC article.
-
Cross-talk and sensitization of bladder afferent nerves.Neurourol Urodyn. 2010;29(1):77-81. doi: 10.1002/nau.20817. Neurourol Urodyn. 2010. PMID: 20025032 Free PMC article. Review.
-
Altered resting state neuromotor connectivity in men with chronic prostatitis/chronic pelvic pain syndrome: A MAPP: Research Network Neuroimaging Study.Neuroimage Clin. 2015 Jun 5;8:493-502. doi: 10.1016/j.nicl.2015.05.013. eCollection 2015. Neuroimage Clin. 2015. PMID: 26106574 Free PMC article.
-
Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS.Oncotarget. 2018 Apr 13;9(28):19623-19639. doi: 10.18632/oncotarget.24714. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29731970 Free PMC article.
-
Beneficial Effects of Inflammatory Cytokine-Targeting Aptamers in an Animal Model of Chronic Prostatitis.Int J Mol Sci. 2020 May 31;21(11):3953. doi: 10.3390/ijms21113953. Int J Mol Sci. 2020. PMID: 32486412 Free PMC article.
References
-
- Alexander RB. Treatment of chronic prostatitis. Nat Clin Pract Urol. 2004;1:2–3. - PubMed
-
- Potts JM. Chronic pelvic pain syndrome: a non-prostatocentric perspective. World J Urol. 2003;21:54–6. - PubMed
-
- Pontari MA, McNaughton-Collins M, O'Leary MP, Calhoun EA, Jang T, Kusek JW, Landis JR, Knauss J, Litwin MS. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int. 2005;96:559–65. - PubMed
-
- Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259–84. - PubMed
-
- Litwin MS, McNaughton-Collins M, Fowler FJ, Jr, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O'Leary MP. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous